Clinical Trial Update: Evaluation of the Bioavailability of Pramlintide [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the bioavailability of pramlintide in patients with type 1 or type 2 diabetes has completed. The document reports the completion of the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Symlin (pramlintide)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED